Megumi Oda

1.6k total citations
68 papers, 1.0k citations indexed

About

Megumi Oda is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Megumi Oda has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 28 papers in Hematology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Megumi Oda's work include Acute Lymphoblastic Leukemia research (29 papers), Childhood Cancer Survivors' Quality of Life (16 papers) and Acute Myeloid Leukemia Research (16 papers). Megumi Oda is often cited by papers focused on Acute Lymphoblastic Leukemia research (29 papers), Childhood Cancer Survivors' Quality of Life (16 papers) and Acute Myeloid Leukemia Research (16 papers). Megumi Oda collaborates with scholars based in Japan, United States and Egypt. Megumi Oda's co-authors include Keizo Horibe, Junichi Hara, Keiko Yumura‐Yagi, Yoshiki Seino, Tsuneo Morishima, Nobuhiro Suzuki, Hiroki Hori, Ryōji Kobayashi, Hiroki Isomura and Nobuko Yamashita and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Megumi Oda

66 papers receiving 1.0k citations

Peers

Megumi Oda
Jack Bartram United Kingdom
Ami J. Shah United States
Nack‐Gyun Chung South Korea
Diane George United States
Jack Bartram United Kingdom
Megumi Oda
Citations per year, relative to Megumi Oda Megumi Oda (= 1×) peers Jack Bartram

Countries citing papers authored by Megumi Oda

Since Specialization
Citations

This map shows the geographic impact of Megumi Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Oda more than expected).

Fields of papers citing papers by Megumi Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Oda. The network helps show where Megumi Oda may publish in the future.

Co-authorship network of co-authors of Megumi Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Oda. A scholar is included among the top collaborators of Megumi Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Oda. Megumi Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hori, Hiroki, Tooru Kudoh, Shin‐Ichiro Nishimura, et al.. (2016). Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. International Journal of Clinical Oncology. 22(2). 387–396. 10 indexed citations
3.
Suga, Shigeru, Bin Chang, Hideki Akeda, et al.. (2015). Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine. Vaccine. 33(45). 6054–6060. 55 indexed citations
4.
Yoshida, Hideki, Toshihiko Imamura, Akiko Saito, et al.. (2015). Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia. PLoS ONE. 10(8). e0136428–e0136428. 14 indexed citations
5.
Kobayashi, Ryōji, Tetsuya Takimoto, Atsuko Nakazawa, et al.. (2014). Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols. International Journal of Hematology. 99(6). 743–749. 11 indexed citations
7.
Torii, Yuka, Hiroshi Kimura, Yoshinori Ito, et al.. (2013). Clinicoepidemiologic Status of Mother-To-Child Infections. The Pediatric Infectious Disease Journal. 32(6). 699–701. 17 indexed citations
8.
Tsukahara, Hirokazu, Kazuaki Chayama, Toshiaki Ishida, et al.. (2011). Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B‐precursor acute lymphoblastic leukemia. Pediatric Blood & Cancer. 59(1). 83–89. 62 indexed citations
9.
Arihiro, Koji, et al.. (2010). Comparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings. Experimental and Therapeutic Medicine. 1(6). 927–932. 7 indexed citations
10.
Miyamura, Takako, Ryuichi Yoshida, Takahito Yagi, et al.. (2010). Successful treatment of unresectable advanced hepatoblastoma: Living liver transplantation after surgical removal of lung metastasis. Pediatric Transplantation. 15(5). E87–91. 5 indexed citations
11.
Park, Hyuntae, Tomohiko Taki, Megumi Oda, et al.. (2009). FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non‐Hodgkin lymphoma. British Journal of Haematology. 145(2). 198–206. 87 indexed citations
12.
Miyamura, Takako, Kazuaki Chayama, Tomoaki Wada, et al.. (2008). Two cases of chronic active Epstein–Barr virus infection in which EBV‐specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation. Pediatric Transplantation. 12(5). 588–592. 6 indexed citations
13.
Ishii, Eiichi, Megumi Oda, Naoko Kinukawa, et al.. (2005). Features and outcome of neonatal leukemia in Japan: Experience of the Japan Infant Leukemia Study Group. Pediatric Blood & Cancer. 47(3). 268–272. 22 indexed citations
15.
Yamashita, Nobuko, Hiroyuki Tanaka, Tadashi Moriwake, et al.. (2003). Analysis of linear growth in survivors of childhood acute lymphoblastic leukemia. Journal of Bone and Mineral Metabolism. 21(3). 172–178. 11 indexed citations
16.
Oda, Megumi, et al.. (2003). Persistence of TEL‐AML1 transcript in acute lymphoblastic leukemia in long‐term remission. Pediatrics International. 45(3). 275–280. 5 indexed citations
17.
Ishii, Eiichi, Mariko Eguchi, Minenori Eguchi‐Ishimae, et al.. (2002). In Vitro Cleavage of theMLL Gene by Topoisomerase II Inhibitor (Etoposide) in Normal Cord and Peripheral Blood Mononuclear Cells. International Journal of Hematology. 76(1). 74–79. 14 indexed citations
19.
Kurosaki, Yuji, Hiroaki Araki, Yutaka Gomita, et al.. (1998). Medication Instructions for Improving the QOL: Lugol's Solution for Internal Use via Soft Drinks Containing Ascorbic Acid.. Japanese Journal of Hospital Pharmacy. 24(6). 677–682. 3 indexed citations
20.
Isomura, Hiroki, Masao Yamada, Mariko Yoshida, et al.. (1997). Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. Journal of Medical Virology. 52(4). 406–412. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026